1 / 2

TERT (134)

Supplementary Fig. 1. All glioblastomas (200). Primary glioblastomas (179). Secondary glioblastomas (21). TERT (134). IDH1 (14). TERT (127). TERT (4). 124. 124. IDH1 (21). 3. 4. 3. None=51. 3 2. 13. None=50. 2. 1p/19q (3). 1p/19q (5). 1p/19q (8). IDH1 (20).

cascata-firbis
Download Presentation

TERT (134)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplementary Fig. 1 All glioblastomas (200) Primary glioblastomas (179) Secondary glioblastomas (21) TERT (134) IDH1(14) TERT (127) TERT (4) 124 124 IDH1(21) 3 4 3 None=51 3 2 13 None=50 2 1p/19q (3) 1p/19q (5) 1p/19q (8) IDH1(20)

  2. Supplementary Fig. 2 Age group [30-49 y] Age group [50-69 y] Age group [70-90 y] Gender (male) TERT mutation IDH1 mutation EGFR amplification TP53 mutation PTEN mutaion p16INK4a deletion LOH 10q LOH 1p LOH 19q * * * P<0.05

More Related